email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
646 - 660
of 3630 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
Next
Eucure Biopharma Licenses Antibody to Syncromune for Personalized Cancer Therapy
$5.00
Available
Zhiyi Bio to Start US Trial of Live Biotherapy for Chemotherapy-Induced Diarrhea
$5.00
Available
Gracell Starts China Trial of Donor-Derived CD-19 CAR-T for Leukemia
$5.00
Available
Innovent Publishes Positive Weight Loss Data from Trial of GLP-1/Glucagon Agonist
$5.00
Available
Bio-Thera Starts China Trial of mAb Biosimilar for Asthma
$5.00
Available
LianBio Stops China Trial of Liver Cancer Drug After Helsinn Asks FDA to Withdraw Approval
$5.00
Available
Accutar Starts China Phase I Trial of AI-developed Protein Degrader for Breast Cancer
$5.00
Available
Harbour BioMed Announces $140 Million Deal to Out-license Autoimmune Therapy to CSPC
$5.00
Available
WuXi Biologics to Partner with Toregem to Develop mAb for Tooth Regeneration
$5.00
Available
Jemincare Out-licenses Prostate Cancer Drug to Roche in $650 Million Deal
$5.00
Available
IASO Signs $162 Million Agreement to Out-License CD19 Binder to Cabaletta For CAR-T
$5.00
Available
JW Therapeutics Approved to Launch CAR-T for Second Lymphoma Indication
$5.00
Available
Innovent Approved to Launch Oncology Drug for Cancers with RET Gene Fusions
$5.00
Available
Tracon Pharma Says PD-L1 Passes Interim Safety Test in Sarcoma Trial
$5.00
Available
Ascletis Doses First Patient in China Trial of THRβ Agonist for NASH
$5.00
Available